Literature DB >> 31087221

Mechanobiological osteocyte feedback drives mechanostat regulation of bone in a multiscale computational model.

Madge Martin1,2, Vittorio Sansalone3, David M L Cooper4, Mark R Forwood5, Peter Pivonka6.   

Abstract

Significant progress has been made to identify the cells and signaling molecules involved in the mechanobiological regulation of bone remodeling. It is now well accepted that osteocytes act as mechanosensory cells in bone expressing several signaling molecules such as nitric oxide (NO) and sclerostin (Scl) which are able to control bone remodeling responses. In this paper, we present a comprehensive multiscale computational model of bone remodeling which incorporates biochemical osteocyte feedback. The mechanostat theory is quantitatively incorporated into the model using mechanical feedback to control expression levels of NO and Scl. The catabolic signaling pathway RANK-RANKL-OPG is co-regulated via (continuous) PTH and NO, while the anabolic Wnt signaling pathway is described via competitive binding reactions between Wnt, Scl and the Wnt receptors LRP5/6. Using this novel model of bone remodeling, we investigate the effects of changes in the mechanical loading and hormonal environment on bone balance. Our numerical simulations show that we can calibrate the mechanostat anabolic and catabolic regulatory mechanisms so that they are mutually exclusive. This is consistent with previous models that use a Wolff-type law to regulate bone resorption and formation separately. Furthermore, mechanical feedback provides an effective mechanism to obtain physiological bone loss responses due to mechanical disuse and/or osteoporosis.

Entities:  

Keywords:  Bone cell population model; Bone remodeling; Co-regulation; Mechanostat; Nitric oxide; Osteocytes; RANK–RANKL–OPG pathway; Sclerostin; Wnt pathway

Year:  2019        PMID: 31087221     DOI: 10.1007/s10237-019-01158-w

Source DB:  PubMed          Journal:  Biomech Model Mechanobiol        ISSN: 1617-7940


  6 in total

1.  Effects of Osteocyte Shape on Fluid Flow and Fluid Shear Stress of the Loaded Bone.

Authors:  Fengjian Yang; Weilun Yu; Xuyang Huo; Hongliang Li; Qiuju Qi; Xiaohang Yang; Nianqiu Shi; Xiaogang Wu; Weiyi Chen
Journal:  Biomed Res Int       Date:  2022-05-30       Impact factor: 3.246

2.  Assessment of Strategies for Safe Drug Discontinuation and Transition of Denosumab Treatment in PMO-Insights From a Mechanistic PK/PD Model of Bone Turnover.

Authors:  Javier Martínez-Reina; José Luis Calvo-Gallego; Madge Martin; Peter Pivonka
Journal:  Front Bioeng Biotechnol       Date:  2022-06-17

3.  Mechanistic PK-PD model of alendronate treatment of postmenopausal osteoporosis predicts bone site-specific response.

Authors:  José L Calvo-Gallego; Peter Pivonka; Rocío Ruiz-Lozano; Javier Martínez-Reina
Journal:  Front Bioeng Biotechnol       Date:  2022-08-17

4.  Ten-Year Simulation of the Effects of Denosumab on Bone Remodeling in Human Biopsies.

Authors:  Duncan C Tourolle; David W Dempster; Charles Ledoux; Daniele Boaretti; Mauricio Aguilera; Najma Saleem; Ralph Müller
Journal:  JBMR Plus       Date:  2021-04-05

5.  Combined Effects of Exercise and Denosumab Treatment on Local Failure in Post-menopausal Osteoporosis-Insights from Bone Remodelling Simulations Accounting for Mineralisation and Damage.

Authors:  Javier Martínez-Reina; José L Calvo-Gallego; Peter Pivonka
Journal:  Front Bioeng Biotechnol       Date:  2021-06-04

6.  Overexpression of Lrp5 enhanced the anti-breast cancer effects of osteocytes in bone.

Authors:  Shengzhi Liu; Di Wu; Xun Sun; Yao Fan; Rongrong Zha; Aydin Jalali; Yan Feng; Kexin Li; Tomohiko Sano; Nicole Vike; Fangjia Li; Joseph Rispoli; Akihiro Sudo; Jing Liu; Alexander Robling; Harikrishna Nakshatri; Bai-Yan Li; Hiroki Yokota
Journal:  Bone Res       Date:  2021-07-06       Impact factor: 13.567

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.